Efficacy and tolerability of ebastine 10 mg plus pseudoephedrine 120 mg in the symptomatic relief of the common cold

European Journal of Internal Medicine

Volumn 15, Issue 4, 2004, Pages 242-247

  Robert, M ^a   Llorens, M ^a   Garcia E ^a   Luria, X ^a  

^a Almirall Prodesfarma S A   (Spain)

Author keywords

Antihistamine; Common cold; Nasal decongestant

Indexed keywords

EBASTINE; PLACEBO; PSEUDOEPHEDRINE;

ADULT; AGED; ARTICLE; ASTHENIA; CLINICAL TRIAL; COMMON COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG TOLERABILITY; EPIGASTRIC PAIN; FEMALE; FEVER; HUMAN; MALE; MULTICENTER STUDY; NAUSEA; PEAK EXPIRATORY FLOW; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; XEROSTOMIA;

EID: 3543135442     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2004.03.009     Document Type: Article

References (23)

1. Campbell A., Michel F.B., Bremard-Oury C., Crampette L., Bousquet J. Overview of allergic mechanisms. Ebastine has more than an antihistamine effect. Drugs. 52(Suppl. 1):1996;15-19
2. Hurst M., Spencer C.M. Ebastine - an update of its use in allergic disorders. Drugs. 59(4):2000;981-1006
3. Roberts D.J., Gispert J. The non-cardiac systemic side-effects of antihistamines: ebastine. Clin. Exp. Allergy. 29(Suppl. 3):1999;151-155
4. Cohen B., Gehanno P. Comparison of the efficacy of ebastine 10 mg and 20 mg once daily with that of cetirizine 10 mg once daily in adults with seasonal allergic rhinitis. A multicentre double-blind study. Drugs. 52(Suppl. 1):1996;26-29
5. De Molina M., Cadahia A., Cano L., Sanz A. Efficacy and tolerability of ebastine at two dose levels in the treatment of seasonal allergic rhinitis. Drug Investig. 1:1989;40-46
6. Ratner P.H., Lim J.C., Georges G.C. Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis. J. Allergy Clin. Immunol. 105(6):2000;1101-1107
7. Benavente V., Eseverri J.L., Botey J., Marin A. Ebastine: treatment of perennial rhinitis in the child. Allerg. Immunol. (Paris). 28(8):1996;277-281
8. Bousquet J., Gaudano E.M., Palma Carlos A.G., Staudinger H. A 12-week, placebo-controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis. Multicentre Study Group. Allergy. 54(6):1999;562-568
9. Davies R.J. Efficacy and tolerability comparison of ebastine 10 and 20 mg with loratadine 10 mg: a double-blind, randomised study in patients with perennial allergic rhinitis. Clin. Drug Investig. 16:1998;413-420
10. Kalis B. Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults. Drugs. 52(Suppl. 1):1996;30-34
11. Reynolds J. Sympathomimetics. Reynolds J. Martindale, the extra pharmacopeia. 1996;1478-1555 Royal Pharmaceutical Society, London
12. Stubner U.P., Toth J., Marks B., Berger U.E., Burtin B., Horak F. Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus xylometazoline nasal spray in nasal congestion. Arzneimittelforschung. 51(11):2001;904-910
13. McFadden E.A., Gungor A., Ng B., Mamikoglu B., Moinuddin R., Corey J. Loratadine/pseudoephedrine for nasal symptoms in seasonal allergic rhinitis: a double-blind, placebo-controlled study. Ear Nose Throat J. 79(4):2000;254. [7-8, 60 passim]
14. Sussman G.L., Mason J., Compton D., Stewart J., Ricard N. The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis. J. Allergy Clin. Immunol. 104(1):1999;100-106
15. Robert M., Orust C., Fabra J.M., Gispert J., Luria X. Ebastine 10 mg+pseudoephedrine 120 g in patients suffering from cholinergic vasomotor rhinitis. EACCI 97 Annual Meeting, Rhodes:1997
16. Luria X., Robert M., Garcia E. Ensayo clínico de ebastina+pseudoefedrina en rinitis alérgica estacional. 19°Congreso Nacional de la Sociedad Española de Alergología e Inmunología Clínica:1994
17. De Molina M., Pinto E., Robert M., Luria X. Eficacia y tolerabilidad de ebastina 10 mg+pseudoefedrina 120 mg retard administrada una vez al día y dos veces al día comparada con placebo en pacientes con síntomas severos de rinitis alérgica estacional. Interasma'95 (South American Congress), Buenos Aires:1995
18. Robert M., Orust C., Fabra J.M., Gispert J., Luria X. Ebastine 10 mg+pseudoephedrine 120 mg in patients suffering from cholinergic vasomotor rhinitis. EAACI'97 Annual Meeting, Rhodes:1997
19. Henauer S.A., Gluck U. Efficacy of terfenadine in the treatment of common cold. A double-blind comparison with placebo. Eur. J. Clin. Pharmacol. 34(1):1988;35-40
20. Gleeson M.J., Youlten L.J., Shelton D.M., Siodlak M.Z., Eiser N.M., Wengraf C.L. Assessment of nasal airway patency: a comparison of four methods. Clin. Otolaryngol. Allied Sci. 11(2):1986;99-107
21. Van Cauwenberge P.B., van Kempen M.J., Bachert C. The common cold at the turn of the millennium. Am. J. Rhinol. 14(5):2000;339-343
22. Mossad S.B. Treatment of the common cold. BMJ. 317(7150):1998;33-36
23. Muether P.S., Gwaltney J.M. Jr. Variant effect of first- and second-generation antihistamines as clues to their mechanism of action on the sneeze reflex in the common cold. Clin. Infect. Dis. 33(9):2001;1483-1488